Related Experiment Videos
Development and characterization of buccoadhesive nifedipine tablets.
1Department of Pharmaceutics, School of Pharmacy and Phamaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. j_varshosaz@hotmail.com
Summary
Carboxymethyl cellulose (CMC) and carbomer (CP) created nifedipine tablets with superior bioadhesion. These buccoadhesive tablets demonstrated controlled release and good in vitro-in vivo correlation for drug delivery.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
Background:
- Nifedipine is a crucial drug for cardiovascular conditions.
- Developing effective controlled-release drug delivery systems is essential for improving patient compliance and therapeutic outcomes.
- Buccoadhesive systems offer potential for sustained drug release and localized delivery.
Purpose of the Study:
- To develop and characterize buccoadhesive controlled-release tablets for nifedipine delivery.
- To evaluate the bioadhesion properties and drug release kinetics of these tablets.
- To assess the in vivo performance and safety of the optimized formulation.
Main Methods:
- Tablets were prepared by direct compression using carboxymethyl cellulose (CMC) and carbomer (CP).
- Bioadhesion was assessed using a modified tensiometry method in vitro.
- Drug release studies were conducted in vitro and in vivo in human volunteers.
- Zero-order release kinetics and adhesion forces were analyzed based on CP:CMC ratios.
Main Results:
- CMC and CP demonstrated superior bioadhesion compared to other polymers.
- The optimal CP:CMC ratio (8:2) yielded the highest adhesion force.
- Tablets with 15% CMC and 35% CP adhered for over 8 hours and showed sustained nifedipine release in vivo (56% at 8h).
- A strong correlation (r²=0.989) was found between in vitro and in vivo drug release.
Conclusions:
- Buccoadhesive tablets formulated with CMC and CP provide effective controlled release of nifedipine.
- The developed system exhibits promising bioadhesion and sustained drug delivery properties.
- The in vitro release profile accurately predicts in vivo performance, supporting its clinical potential.